Health
Researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk – ABS-CBN News
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among…
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors – cold viruses used to deliver vaccine material – send some of their payload into the nucleus of cells, where some of the instructions…
-
General24 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News24 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business24 hours agoLessons from Warren Buffett’s ‘acts of omission’